Aterian (ATER) Q3 2024 earnings summary

Executive summary

• Net revenue for Q3 2024 was $26.2 million, down 34% year-over-year, mainly due to SKU rationalization, stockouts, and softer consumer demand.

• Gross margin improved to 60.3% from 49.4% year-over-year, reflecting SKU rationalization, product mix improvements, and less inventory liquidation.

• Net loss for Q3 2024 was $1.8 million, a 71.7% improvement from $6.3 million in Q3 2023.

• Adjusted EBITDA turned positive at $0.5 million, a $4.9 million improvement year-over-year and the second consecutive quarter of profitability.

• Strategic focus on six core brands, cost-cutting, and restructuring, but substantial doubt remains about ability to continue as a going concern due to ongoing losses and reliance on outside capital.

Financial highlights

• Q3 2024 gross profit: $15.8 million (60.3% margin); contribution margin rose to 17% from 3% year-over-year.

• Adjusted EBITDA was $0.5 million, up from a $(4.4) million loss in Q3 2023; operating loss narrowed to $1.7 million.

• Cash balance at September 30, 2024, was $16.1 million; outstanding debt under credit facility was $6.7 million.

• Inventory reduced to $16.6 million from $31.5 million year-over-year.

• Operating cash flow for nine months ended September 30, 2024 was $2.2 million, compared to $(8.5) million in the prior year.

Outlook and guidance

• Q4 2024 net revenue expected between $22.5 million and $25.5 million, a 27% decrease year-over-year, with adjusted EBITDA projected to be approximately break-even.

• Gross margin for Q4 expected to remain in line with year-to-date results.

• Management expects continued focus on profitable core products and further SKU reduction.

• Confident in achieving consistent adjusted EBITDA profitability for the second half of 2024; 2025 expected to shift from stabilization to growth, with focus on omnichannel expansion and organic product launches.

• The company may seek additional outside capital and is monitoring profitability and cash flow closely.